Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy

被引:46
作者
Seggewiss, H [1 ]
Faber, L [1 ]
Gleichmann, U [1 ]
机构
[1] Ruhr Univ Bochum, NRW Klin, Kardiol Klin,Heart & Diabet Ctr, Herz & Diabetzentrum,Dept Cardiol, D-32545 Bad Oeynhausen, Germany
关键词
hypertrophic obstructive cardiomyopathy transluminal ablation; alcohol induced occlusion; remodeling; myocardial contrast echocardiography;
D O I
10.1055/s-2007-1013118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Percutaneous transluminal septal myocardial ablation (PTSMA) by alcohol-induced occlusion of septal branches with resulting reduction of LV outflow-tract gradient (LVOTG) is a new treatment option in symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM). Methods: In 1996 and 1997 we treated 114 symptomatic patients (56 female; age 53.3 +/- 15.6 years; 5 patients with prior myectomy and 5 with DDD pacer; most in NYHA class ill. Five patients underwent re-PTSMA after failed first treatment. In the first SO patients 1 to 3 septal branches were occluded by injection of 3.4 +/- 1.6 mi absolute alcohol via the central lumen after balloon occlusion of the proximal part: of the septal branch. In the remaining patients myocardial contrast echocardiography was available, so that: only one branch needed to be occluded. Results: LVOTG reduction was achieved in 107 (94%) patients: at rest from 73.8 +/- 36.5 to 18.6 +/-19.7 mmHg (p < 0.00001). Maximal CK rise was 647 +/- 330 U/L, Two (1.8%) patients died during hospital stay. Due to permanent trifascicular block 11 (9.6%) patients required a permanent pacemaker. At 3 months follow-up in 87 patients we observed no cardiac complications, a further LVOTG reduction in 61% patients, an ongoing symptomatic improvement (NYHA I or 11; p<0.0001 vs. pre PTSMA), and significant reduction of the left posterior wall thickness. Conclusions: PTSMA of HOCM results in significant reduction of LVOTG. Careful monitoring during hospital stay is necessary because of the? potential risks of the induced therapeutic infarction. Mid-term follow-up showed ongoing symptomatic improvement without: cardiac complications. Remodeling after circumscribed septal infarction results in further LVOTG reduction in over 50% of the patients.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 24 条
[1]  
Bhargava B, 1997, CATHETER CARDIO DIAG, V41, P56, DOI 10.1002/(SICI)1097-0304(199705)41:1<56::AID-CCD14>3.0.CO
[2]  
2-O
[3]   TRANSCORONARY CHEMICAL ABLATION OF VENTRICULAR-TACHYCARDIA [J].
BRUGADA, P ;
DESWART, H ;
SMEETS, JLRM ;
WELLENS, HJJ .
CIRCULATION, 1989, 79 (03) :475-482
[4]  
FABER I, 1997, EUR HEART J SUPPL, V18, P368
[5]   Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with respect to myocardial contrast echocardiography [J].
Faber, L ;
Seggewiss, H ;
Fassbender, D ;
Bogunovic, N ;
Strick, S ;
Schmidt, HK ;
Gleichmann, U .
ZEITSCHRIFT FUR KARDIOLOGIE, 1998, 87 (03) :191-201
[6]   Guiding of percutaneous transcoronary septal myocardial ablation in hypertrophic obstructive cardiomyopathy by myocardial contrast echocardiography [J].
Faber, L ;
Seggewiss, H ;
Fassbender, D ;
Strick, S ;
Gleichmann, U .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 1998, 11 (05) :443-448
[7]  
Gietzen F., 1997, European Heart Journal, V18, P468
[8]  
GLEICHMANN U, 1996, DEUT MED WOCHENSCHR, V21, P679
[9]   SURGICAL-MANAGEMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - EARLY AND LATE RESULTS [J].
HERIC, B ;
LYTLE, BW ;
MILLER, DP ;
ROSENKRANZ, ER ;
LEVER, HM ;
COSGROVE, DM .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :195-208
[10]  
Kappenberger L, 1997, EUR HEART J, V18, P1249